Here are four highlights:
1. The system and catheters are now cleared for use in sphincter measurements in patients with such disorders as gastroparesis and fecal incontinence.
2. These new indications expand the use of EndoFLIP beyond the esophagus and stomach.
3. CMS provides payments for the use of EndoFLIP in the esophagus under the CPT code 91040, which became effective Jan. 1, 2016.
4. Founded in 2006 and based in Ireland, Crospon develops minimally invasive medical devices for monitoring, diagnosis and therapy in the areas of minimally invasive surgery and gastroenterology.
More articles on GI & endoscopy:
FMT helps reduce recurring episodes of C. Diff in children: 4 findings
GIQuIC registry hits 3M colonoscopy cases: 5 things to know
Certain body sugars help prevent UC & colon cancer — 5 points
